Vasu, S., Bandettini, W. P., Hsu, L., Kellman, P., Chen, M. Y., Wilson, J., . . . Arai, A. E. (2011). Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients. BioMed Central.
Citação norma ChicagoVasu, Sujethra, et al. Regadenoson Is a Better Myocardial Vasodilator Than Dipyridamole in Normal Volunteers, but the Data Is Less Compelling in Patients. BioMed Central, 2011.
MLA CitationVasu, Sujethra, et al. Regadenoson Is a Better Myocardial Vasodilator Than Dipyridamole in Normal Volunteers, but the Data Is Less Compelling in Patients. BioMed Central, 2011.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.